All Posts
Why next week’s Dot Plot from the Fed is more important than ever after a hot inflation report
There’s not much question of what the Federal Reserve will do at its March 20 meeting. The odds–99% on the CME Fed Watch Tool–are that the Fed will do nothing and leave interest rates at the current 5.25%-5.50% benchmark. But that day the Fed will also release its most recent quarterly revision of its economic projections for the year ahead, the Dot Plot. And those projections will have, potential, market moving power. The central question: Will the Fed hold to its projection of 2 interest rate cuts in 2024 or will the bank, worried by recent evidence that inflation has been stubbornly high in recent months, point toward just one cut by the end of the year?
Please Watch My New YouTube Video: Quick Pick Qualcomm
Today’s Quick Pick is Qualcomm, (QCOM). I always look for product momentum in technology stocks, and Qualcomm’s pipeline is very promising. The company reported a good first quarter for 2024 but I’m focused on growth for their Snapdragon chip which is used in cell phones, cars, and the internet of things. Qualcomm has recently renewed its chip agreements with Apple and Samsung. Samsung’s Galaxy 24 is the first cell phone to include AI technology powered by Snapdragon and sales are up 13% year over year from 2023 and 47% from 2024. It’s likely more companies will be looking to add AI to their phones and I think Qualcomm has a leading position in that market. A new Snapdragon product, X-Elite, will put AI on PCs and is coming out this year. In 2023 the Snapdragon chip was also installed in infotainment modules for 75 new car models and the company’s automotive revenue is up about 12% this quarter. The Internet of Things is growing more slowly but is still growing. Morningstar says the stock is trading at a 22% premium, but I find that to be very, very conservative. While this stock isn’t a bargain at the moment this is a decent time to get in on an AI stock with promising pipeline momentum, and I don’t see it being more reasonable any time soon. I added Qualcomm to my Jubak’s Picks Portfolio on January 15, 2024. The position is up 23.5% since then as of the close on March 12.
Core CPI inflation disappoints again for February
Core CPI inflation came in hotter than expected in February for a second straight month. The core Consumer Price Index, which excludes food and energy prices, increased 0.4% from January, the Bureau of Labor Statistics reported today. The year over year inflation rate rose to 3.8%. Economists had been projecting 3.7% annual rate. Core CPI over the past three months rose an annualized 4.2%, the highest annual rate since June. That adds to worries that the improvement in inflation has stalled in recent months.
Please Watch My New YouTube Video: The Magnificent Five?
Today’s video is The Magnificent Five? The Magnificent Seven were the main drivers of market success at the end of 2023 and the beginning of 2024. But what happens when the Magnificent Seven are more like a magnificent Five, or even four? The original Magnificent Seven included Apple, Amazon, Meta Platforms, Microsoft, Alphabet (Google), Nvidia, and Tesla. Both Tesla and Apple have taken major hits largely due to problems with China. China’s regulations have made it harder to sell Apple products in the country in the government’s effort to push domestic goods. Apple sales in China are down 16-17%. in the first six weeks of 2024. This, alongside a Wall Street perception that Apple is behind in AI technology, has brought Apple shares down 12% for 2024. As for Tesla, China is producing massive numbers of cheaper electric vehicles that are increasingly exported globally (with the exception of the United States where high tariffs on Chinese electric vehicles limit sales) leaving Tesla down 25% in 2024. Google is also down 5% year to date though it may be too soon to write Alphabet off as “not magnificent” just yet. Both Apple and Tesla are no longer pacing the market and are indeed lagging. Bad thing? Good thing? I’d vote for “good thing.” The rally is beginning to spread out from a handful of big names. The only thing that makes me a bit wary is that so many investors are hoping to make money on speculative moves while the market is moving sideways. Those moves could cause volatility in a market that is otherwise likely to stay steady until we get big news from the Federal Reserve on interest rate cuts in June or so.
Saturday Night Quarterback says (on a Sunday), For the week ahead don’t expect…
A month after the stock market was rocked by a worse-than-expected inflation report, investors are fearing a reprise when the latest data arrives on Tuesday. Last Thursday stocks rallied when Fed Chair Jerome Powell said in his testimony before the Senate that the central bank is “not far” from being ready to cut interest rates. But this week Fed officials are in their regular blackout period ahead of their meeting on March 19 and 20. Absent Fed commentary on the inflation report, stocks may be volatile again.
Use the plunge in Viking Therapeutics as a buying opportunity
Shares of Viking Therapeutics (VKTX) are down norther 6.22% as of noon today in New York. That comes after the stock dropped 18.84% yesterday. I think that the market thinking here by and large wrong and I’d use the big painful drop as an opportunity to buy more shares of Viking Therapeutics.
Job adds surprisingly strong; unemployment rate climbs
Can we just agree that they way we measure the labor market is nuts? Today’s report on the U.S. economy is a case in point. Employers added 275,000 jobs in February, the Labor Department reported Friday. But the unemployment rate rose to 3.9% from 3.7%.
Tesla to lose money in 2024? From Magnificent 7 to Market Dog in 3 months
Right now Tesla (TSLA) is a case study in how sentiment on a stock changes, how long it takes sentiment to change (and recover), and the stages of sentiment change. You understanding of this process should be our guide to whether you want to own Tesla and when. Tesla (TSLA) could potentially lose money in 2024, Morgan Stanley’s Adam Jonas wrote in a note to investors this week. And he cut his Tesla earnings projections by 25% to $1.51 a share from a prior $2.04. Gross profit margins will fall to 11.4% (excluding regulatory credits that Tesla gets paid by automakers looking to meet EPA mileage and emissions rules.) And this is from a Tesla bull.
Another (yep, another) reason to buy Novo Nordisk today
Yes, I know this is my third post (plus video) on diabetes/weight-loss drug leader Novo Nordisk (NVO) in three weeks. But the company keeps pumping out research updates that keep powering the stock higher. Think of this as a momentum stock where the momentum comes from the R&D pipeline and not moves in the share price. (The last post was https://jubakam.com/another-reason-t…-success-for-glp/) Today, the company reported early results for a next-generation oral weight loss drug called amycretin, showing a 13.1% weight loss after 12 weeks. That’s a bigger weight-loss than either Novo Nordisk’s own Wegovy or Eli Lilly’s (LLY) competing drug Zepbound. Shares of Novo Nordisk were up 8.9% today to $135.85. I added them to my Jubak’s Picks Portfolio on February 20. The position is up 11.91% since then.
Apple is a sell at least until its developers conference in June
Apple (AAPL) shares are down 12% for 2024 to date as of March 5. But I don’t think Apple’s troubles are over. And it will take some pretty fast taking at the June WWDC (World Wide Developers Conference) to reverse the downtrend in the shares. Absent a knock-it-out-of-the-park performance from CEO Tim Cook, I think the weakness will continue the company’s product announcements in September. And maybe longer. Those of you who have long memories may recall that I sold my shares of Apple in my 12-18 month Jubak’s Picks Portfolio back on September 12, 2023 at $176.30 a share. (I kept my long-term position in Apple in my 50 Stock Portfolio.) That sell turned out to be early. Painfully early. The stock hit a 2023 high of $198 on December 14. And it has only recently moved below my September sell, closing at $169.62 on March 6. But the iPhone China problem that led to that sell call has gotten worse. And since then Apple has developed an AI problem as well. And unfortunately the China problem and the AI problem mix to form an especially potent negative brew.
Here’s why lithium producer Albemarle was down 17.9% today
Today Albemarle (ALB) announced that it would sell $1.75 billion in ADRs to fund capital spending during the collapse in lithium prices. The offer will be for a mandatory convertible preferred with a 7% to 7.5% coupon. The plunge is a reaction to the company having to do a capital raise at the bottom for the lithium market
Another reason to buy Novo Nordisk: Kidney trial success for GLP
Back on February 20, I posted a video recommending a buy of Novo Nordisk (NVO). In the video, “Buy GLP-1,” I said that the stock, along with Eli Lilly (LLY) was riding the momentum of increased sales of GLP-1 drugs, originally developed to treat diabetes, as weight-loss drugs. Buy, I said, despite the huge run-up in the shares, because new trials and analysis of existing data were pointing to expanded uses for the drugs. Today, Novo Nordic announced exactly the kind of news that I had talked about.
Please Watch My New YouTube Video: Stock Pick of the Week Stripe
Today’s Quick Pick is Stripe. Stripe isn’t public yet but will likely go public in late 2024 or in 2025. This is an alert to prepare for this IPO. Stripe started in 2011 and is the “Paypal of its time.” I use both platforms and I find Stripe the more powerful and more user-friendly payment platform. Stripe recently did a private, series H deal that valued the company at $65 billion. Paypal, its major competitor (along with Square), has a market cap of $65 billion. I think this will be a very hot, oversubscribed IPO share you can make a quick profit by flipping the shares on IPO day. The recent Series H offer means that Stripe probably won’t go public until the last half of 2024, at the earliest, or more likely 2025. Which give you time to get your ducks in a row in order to put in a bid for some shares in the offering. Talk to your broker now to ensure you sign all the right paperwork and meet eligibility requirements for IPO offers. If you get that started now, you’ll be able to place an order for IPO shares when they’re available. Stripe revenue is at $14 billion with about 19% of the market share versus 42% for PaylPal. The company has just turned EBITDA profitable, a major milestone. This is an appealing IPO and something to start preparing for even though it may be a little ways down the road.
Long-term investors! This is the most important trend to think about–the global savings glut is ending
Way back in 2005, shortly before he became chair of the Federal Reserve, economist Ben Bernanke proposed that the world was seeing a long-term glut of savings. With the world awash in cash as a result of massive numbers of people in the developing world entering the job market, and as the Baby Boom generation (and others) hit its peak earning years, and as relatively low inflation and rising real wages freed up more cash for many consumers, long-term interest rates would stay low and remain low for longer. The thesis looks, in retrospect, to have been massively correct. The global economy did experience a long period of extraordinarily low interest rates, with interest rates turning negative for important chunks of the the world. Now, it looks like the long-term trend has gone into reverse. We’re headed into a period of cash scarcity.
My 10 Penny Stock Homeruns Pick #7 L’Occitane International LCCTF
Although I’m selling Natura out of my portfolio and my penny stock list, I do want to keep exposure to global beauty sector, however. I like the high margins and I like the correlation between sales of beauty products and rising incomes in developing economies. My pick for this iteration of my penny stock list is L’Occitane International (LCCTF)
Jim’s Stock Alerts
Download Jim’s eBook for Free
